Jacobsen Pharma Consultancy A/S has been acquired by PharmaLex GmbH
PharmaLex GmbH, a portfolio company of the funds advised by AUCTUS, has acquired pharma services provider Jacobsen Pharma Consultancy A/S (Jacobsen Pharma). PharmaLex GmbH continues its expansion strategy, opening up the Scandinavian pharmaceutical market. Financial details of this transaction have not been disclosed.
Jacobsen Pharma is a privately owned Danish company offering comprehensive consultancy services to the pharmaceutical and associated industries, from early product development right through to licensing and beyond. Jacobsen Pharma is specialized in providing regulatory affairs, development management and project management support.
In October 2014, funds advised by AUCTUS acquired a controlling stake in YES Pharma Services, a highly specialized service provider in the fields of regulatory affairs, product development and drug safety for pharmaceuticals, medical devices and cosmetics. AUCTUS invested in a growth market at the interface between the pharmaceutical industry and business process outsourcing. After acquiring the company, a rapid growth path was taken with the acquisitions of ActioMed and Wainwright in the second half of 2015, which found its peak in the merger with PharmaLex at the end of 2015.
Oaklins' team in Denmark was mandated to assist the owner in the divestment of Jacobsen Pharma to PE-backed PharmaLex GmbH.



Anette Jacobsen
CEO, Jacobsen Pharma Consultancy A/S
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more